United States · Biopharma startup
United States · Aduro BioTech
Aduro BioTech is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies.
Funding reportedLast round: Post ipo equity
What company datasets say Aduro BioTech raised
Funding, as reported
Reported in all$360Min dollars
Rounds12
Last roundPost ipo equity
Last round dateFeb 2019
Investors listed10
Founders and team
From Aduro BioTech's own website and the SEC filings it signed: 14 on the team.
- Chris CannonVice President of Growth
- Gunawan HerriChief Technology Officer
- Lance HendrixChief Information Security Officer
- Renee PetrieChief Product Officer
- Sudhir WadhwaChief Data and AI Officer
- Amber BlackburnDirector of Member Operations
- Cara CynkarDirector of Client Strategy & Engagement
- Jessica KostewiczDirector of Client Experience
- Justin SmithDirector of IT
- Dirk G. BrockstedtExecutive Officeri
- Gregory W. SchaferExecutive Officeri
- Jennifer W. LewExecutive Officeri
- Stephen IsaacsExecutive Officer, Directori
- Thomas W. DubenskyExecutive Officeri
On the board, as filediFrank McCormickGerald David ChanRoss HaghighatStephanie O'BrienWilliam Greenman
Biopharma in United States
Startups like it
Altos LabsSan Francisco · founded 2021
VaxcyteSan Carlos · founded 2013
Madrigal PharmaceuticalsConshohocken · founded 2011
Harmony BiosciencesPlymouth Meeting · founded 2017
Kura OncologyLa Jolla · founded 2014
ImmunovantNew York · founded 2018
SolugenHouston · founded 2016
Dianthus TherapeuticsWaltham · founded 2019
Is this your company?
Add your raise, your deck and your story, and put Aduro BioTech in front of investors. Or tell us what we have wrong.